The filing comes two months after the long-term care business was ordered to pay $949 million when a federal court found it liable for filing fraudulent claims for some prescription drugs.
Demand for obesity treatments has soared recently, due to unprecedented weight loss provided by regular injections of market leaders Wegovy from Novo Nordisk and Zepbound from Indianapolis-based Eli Lilly and Co.
Evidence from clinical trials shows that GLP-1s have benefits beyond weight loss, preventing related chronic conditions and ultimately blunting health-plan costs. But the savings might take decades, experts say.
Other parts of Indiana’s HIP 3.0 proposal are still under consideration, including an expansion on provider taxes, cost-sharing requirements and wellness incentives.
Hospital leaders who spoke with Inside INdiana Business emphasized the bill wouldn’t increase funding, it would give hospitals access to funding that’s already been allocated.
In explaining the rising prices, insurers and employers point to two recent factors: the tariffs on pharmaceutical imports and the high cost of new obesity treatments.
Planned Parenthood said Thursday’s ruling means that more than 1.1 million patients can’t use their Medicaid insurance at its health centers.
President Donald Trump signed a memo Tuesday that directs the FDA and other agencies to step up enforcement against ubiquitous prescription drug ads on TV, websites and social media.
The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational complexity and speed up decision-making as the company faces a more competitive market for obesity drugs.
The threat comes as Trump also pressures drugmakers to lower prices of pharmaceuticals in the United States.
SIHO Insurance Services is tackling the gargantuan challenge of growth in the employer-based benefits market in Indianapolis and across the state.
Indiana ranks 11th among the states in terms of the percentage of population with medical debt in collections, one survey shows.
The revamped vaccines target a newer version of the continuously evolving virus and are set to begin shipping soon.
The company’s shares rose as much as 4.3% Tuesday after Eli Lilly announced the trial results for orforglipron.
Price increases could be especially stark in individual coverage marketplaces, where insurers also are predicting the federal government will end some support that helps people buy coverage.
Testimony on Monday set the stage for an interim committee to find a balance between growing medical debt weighing down Hoosiers and allowing health care providers to collect what’s owed.
Health Secretary Robert F. Kennedy Jr. announced Tuesday that 22 projects, totaling $500 million, to develop vaccines using mRNA technology will be halted.
Hair loss isn’t new. What’s different today, experts say, is that male anguish about it has never been more evident. Social media, dating apps, “Zoom dysphoria” and a sometimes predatory marketplace are stoking the anxiety.
Trump administration officials have offered mixed messages about GLP-1s and whether they should be relied upon for weight loss by obese and overweight Americans.
Parkview said the hospital would be roughly 200,000 square feet, accommodate up to 40 inpatient beds and offer a 24/7 emergency department.
